Recurrent seizure at 12 months · children with febrile seizures
Intermittent oral or rectal diazepam probably leads to lower recurrent seizure at 12 months compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Recurrent seizure at 18 months · children with febrile seizures
Intermittent oral or rectal diazepam may leads to lower recurrent seizure at 18 months compared with placebo or no treatment (low certainty).
1 finding from 1 review
Recurrent seizure at 24 months · children with febrile seizures
Intermittent oral or rectal diazepam leads to lower recurrent seizure at 24 months compared with placebo or no treatment (high certainty).
1 finding from 1 review
Recurrent seizure at 36 months · children with febrile seizures
Intermittent oral or rectal diazepam may leads to lower recurrent seizure at 36 months compared with placebo or no treatment (low certainty).
1 finding from 1 review
Recurrent seizure at 48 months · children with febrile seizures
Intermittent oral or rectal diazepam probably leads to lower recurrent seizure at 48 months compared with placebo or no treatment (moderate certainty).
1 finding from 1 review
Recurrent seizure at 60 months or greater · children with febrile seizures
It is very uncertain whether intermittent oral or rectal diazepam changes recurrent seizure at 60 months or greater compared with placebo or no treatment (very low certainty).
1 finding from 1 review
Complete cure, at least 3 months after the end of treatment · People with American cutaneous and mucocutaneous leishmaniasis
Oral miltefosine (50 mg for 28 days) probably leads to higher complete cure, at least 3 months after the end of treatment compared with placebo (same regimen) (moderate certainty).
1 finding from 1 review
Adverse effects (number of participants who had the event) · People with American cutaneous and mucocutaneous leishmaniasis
Oral miltefosine (50 mg for 28 days) probably leads to higher adverse effects (number of participants who had the event) compared with placebo (same regimen) (moderate certainty).
1 finding from 1 review
Recurrence · People with American cutaneous and mucocutaneous leishmaniasis
Oral miltefosine (50 mg for 28 days) showed no clear difference in recurrence compared with placebo (same regimen) (low certainty).
1 finding from 1 review
FEV1 % predicted: absolute change from baseline · adults and children with cystic fibrosis
The review found no eligible studies for this question.
2 findings from 1 review
Quality of life · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in BMI · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Time to next exacerbation · adults and children with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · adults and children with cystic fibrosis
1 finding from 1 review
All‐cause mortality · people with paracetamol (acetaminophen) overdose
1 finding from 1 review
Hepatotoxicity · people with paracetamol (acetaminophen) overdose
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neonatal mortality · neonates with fast breathing alone
Comparison 2: 7 days oral amoxicillin showed no clear difference in neonatal mortality compared with 7 days injectable benzylpenicillin + injectable gentamicin (low certainty).
1 finding from 1 review
Early neonatal mortality · neonates with fast breathing alone
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Late neonatal mortality · neonates with fast breathing alone
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Sepsis‐specific neonatal mortality · neonates with fast breathing alone
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found